BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16557278)

  • 1. Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis.
    Giatromanolaki A; Koukourakis MI; Turley H; Sivridis E; Harris AL; Gatter KC;
    Mod Pathol; 2006 May; 19(5):701-7. PubMed ID: 16557278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
    Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
    Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
    Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications.
    Giatromanolaki A; Sivridis E; Brekken R; Thorpe PE; Anastasiadis P; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2001 Nov; 92(10):2569-77. PubMed ID: 11745191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
    Giatromanolaki A; Koukourakis MI; Pezzella F; Sivridis E; Turley H; Harris AL; Gatter KC
    Hematol Oncol; 2008 Dec; 26(4):219-24. PubMed ID: 18461646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium.
    Punyadeera C; Thijssen VL; Tchaikovski S; Kamps R; Delvoux B; Dunselman GA; de Goeij AF; Griffioen AW; Groothuis PG
    Mol Hum Reprod; 2006 Jun; 12(6):367-75. PubMed ID: 16648151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle.
    Meduri G; Bausero P; Perrot-Applanat M
    Biol Reprod; 2000 Feb; 62(2):439-47. PubMed ID: 10642585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
    Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
    J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of vascular endothelial growth factor and its receptors, flt-1 and kinase insert domain-containing receptor in normal human endometrium during menstrual cycle].
    Wang H; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 2002 Dec; 37(12):729-32. PubMed ID: 12622916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus.
    Fox SB; Turley H; Cheale M; Blázquez C; Roberts H; James N; Cook N; Harris A; Gatter K
    J Pathol; 2004 Mar; 202(3):313-20. PubMed ID: 14991896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
    Wang H; Chen G; Zhang B
    Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.
    Giatromanolaki A; Sivridis E; Bechrakis NE; Willerding G; St Charitoudis G; Foerster MH; Gatter KC; Harris AL; Koukourakis MI
    Clin Exp Metastasis; 2012 Jan; 29(1):11-7. PubMed ID: 21984395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia and activated VEGF/receptor pathway in multiple myeloma.
    Giatromanolaki A; Bai M; Margaritis D; Bourantas KL; Koukourakis MI; Sivridis E; Gatter KC
    Anticancer Res; 2010 Jul; 30(7):2831-6. PubMed ID: 20683019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
    Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumor transforming gene (PTTG) stimulates thyroid cell proliferation via a vascular endothelial growth factor/kinase insert domain receptor/inhibitor of DNA binding-3 autocrine pathway.
    Kim DS; Franklyn JA; Boelaert K; Eggo MC; Watkinson JC; McCabe CJ
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4603-11. PubMed ID: 16926250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy.
    Sugino N; Kashida S; Karube-Harada A; Takiguchi S; Kato H
    Reproduction; 2002 Mar; 123(3):379-87. PubMed ID: 11882015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.